BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5806615)

  • 1. [Oxidative degradation of adrenaline solutions: study of the intermediate stages and their analytic value for the control of this solute].
    Martin F
    J Pharm Belg; 1969; 24(3):151-61. PubMed ID: 5806615
    [No Abstract]   [Full Text] [Related]  

  • 2. pH control of nucleophilic/electrophilic oxidation.
    Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA
    Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrophotometric determination of adrenaline with an oxidative column in a FIA assembly.
    Kojło A; Martinez Calatayud J
    J Pharm Biomed Anal; 1990; 8(8-12):663-6. PubMed ID: 2100603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation and degradation products of papaverine. Part II[1]: investigations on the photochemical degradation of papaverine solutions.
    Girreser U; Hermann TW; Piotrowska K
    Arch Pharm (Weinheim); 2003 Sep; 336(9):401-5. PubMed ID: 14528487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method development for the enantiomeric purity determination of low concentrations of adrenaline in local anaesthetic solutions by capillary electrophoresis.
    Sänger-van de Griend CE; Ek AG; Widahl-Näsman ME; Andersson EK
    J Pharm Biomed Anal; 2006 Apr; 41(1):77-83. PubMed ID: 16303275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of horseradish peroxidase catalyzed epinephrine oxidation: obligatory role of endogenous O2- and H2O2.
    Adak S; Bandyopadhyay U; Bandyopadhyay D; Banerjee RK
    Biochemistry; 1998 Dec; 37(48):16922-33. PubMed ID: 9836585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prediction system of oxidation reaction as a solid-state stress condition: applied to a pyrrole-containing pharmaceutical compound.
    Kawaguchi-Murakami Y; Fukutsu N; Kajiro T; Araki T; Murakami T; Kawasaki T; Kishi N; Konno M
    J Pharm Biomed Anal; 2009 Oct; 50(3):328-35. PubMed ID: 19497698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrophotometric analysis of raloxifene hydrochloride in pure and pharmaceutical formulations.
    Dharuman J; Ravichandran V; Thirumoorthy N; Dharamsi A
    Pharmazie; 2004 Sep; 59(9):720-1. PubMed ID: 15497756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The early stages of the oxidation of adrenaline in dilute solution.
    TRAUTNER EM; BRADLEY TR
    Aust J Sci Res B; 1951 Aug; 4(3):303-43. PubMed ID: 14886277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stabilization of adrenaline solutions. 2. The stability of adrenaline solutions].
    Thoma K; Struve M
    Pharm Acta Helv; 1986; 61(2):34-41. PubMed ID: 3960936
    [No Abstract]   [Full Text] [Related]  

  • 11. [The stability of commercial adrenaline solutions. 3. The stability of adrenaline solutions].
    Thoma K; Struve M
    Pharm Acta Helv; 1986; 61(3):66-8. PubMed ID: 3714749
    [No Abstract]   [Full Text] [Related]  

  • 12. [The photo- and thermostability of adrenaline solutions. 1. The stability of adrenaline solutions].
    Thoma K; Struve M
    Pharm Acta Helv; 1986; 61(1):2-9. PubMed ID: 3952103
    [No Abstract]   [Full Text] [Related]  

  • 13. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products.
    Hadad GM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of short-term tests for oxidation studies of drugs. 2. Kinetics of 2-mercaptobenzthiazole oxidation].
    Kottke D; Beck K; Beyrich T
    Pharmazie; 1984 Aug; 39(8):546-8. PubMed ID: 6504978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
    Wu Y
    Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
    Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
    J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A contribution to the stability of watery adrenaline bitartrate eye drops].
    Fürtig W; Methke I
    Pharm Prax; 1965; 11():248-51. PubMed ID: 5888294
    [No Abstract]   [Full Text] [Related]  

  • 18. [Photometric determination of codein and ethylmorphine, separate and combined in patent medicines].
    Lang E
    Pharmazie; 1970 Aug; 25(8):493. PubMed ID: 5495309
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug analysis. IX. Stability of adrenaline in nose drops containing boric acid and a comparison of the results of various methods of its control].
    Subert J; Slais K
    Cesk Farm; 1983 Dec; 32(9-10):343-7. PubMed ID: 6667519
    [No Abstract]   [Full Text] [Related]  

  • 20. An ion-pair high-performance liquid chromatography method for stability studies of epinephrine acid tartrate in injectable solution.
    Zarghi A; Amini M; Alesahebfosul S
    Boll Chim Farm; 2001; 140(2):115-8. PubMed ID: 11417386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.